As a health-conscious modern individual, diabetes has become an undeniable issue in our daily lives. With the advancement of medical technology, Japan's research in the field of diabetes treatment is progressing rapidly. This article, from the perspective of a Chinese individual, aims to provide a detailed introduction to some commonly prescribed diabetes medications in Japan, hoping to offer more references for readers facing this health problem.
The Unique Aspects of Diabetes Treatment in Japan
Before delving into specific medications, let's first understand the unique aspects of diabetes treatment in Japan. Compared to China, Japan places a greater emphasis on individualization and precision in diabetes treatment. Doctors formulate more precise treatment plans based on a patient's specific conditions, including blood sugar levels, weight, age, and other factors. This individualized approach is also reflected in the selection of prescription medications.
DPP-4 Inhibitors: マリゼブ錠 (Omarigliptin Tablets)
- Mechanism of Action
DPP-4 inhibitors belong to a class of drugs that enhance the effects of incretin by inhibiting the activity of dipeptidyl peptidase-4 (DPP-4). マリゼブ錠 is a DPP-4 inhibitor primarily working by inhibiting the activity of dipeptidyl peptidase-4 (DPP-4), prolonging the half-life of incretin in the bloodstream. Incretin increases after food intake, stimulating the pancreas to release insulin and inhibiting glucagon, ultimately regulating blood sugar levels. In Japan, マリゼブ錠 (Omarigliptin Tablets) is one of the representatives of this class.
https://medjp.com/products/3bd13b28909048bd96394a3a7420e3dd
- Uses
Primarily suitable for patients with type 2 diabetes, especially those who require better blood sugar control after meals. Due to its high selectivity, it not only demonstrates significant advantages in therapeutic effects but also possesses excellent characteristics in terms of medication safety.
DPP-4 Inhibitors: ザファテック (Zafatek - Trelagliptin)
- Mechanism of Action
ザファテック is another common DPP-4 inhibitor, with a mechanism of action similar to マリゼブ錠. It enhances the effects of incretin by inhibiting DPP-4, thereby regulating insulin secretion and suppressing the rise in blood sugar levels.
https://medjp.com/products/0064cfdd9eb040178ae1adb128ce6616
https://medjp.com/products/77ad1367579c4c87a15fe49690150b1b
- Uses
It is suitable for type 2 diabetes patients who need better blood sugar control after meals. This medication has excellent selectivity and tolerance, making it one of the first-line drugs in the current treatment of diabetes.
Biguanide Medication: メトグルコ錠 (Metformin)
- Mechanism of Action
メトグルコ錠 belongs to the biguanide class of drugs. It lowers blood sugar levels by inhibiting hepatic gluconeogenesis, increasing sensitivity to insulin in peripheral tissues, and slowing down the absorption of glucose in the intestines.
https://medjp.com/products/fb6e55e01781403cbc127c6a3c2bd145
https://medjp.com/products/1707d0267c2d48b293e2acad6f8c56e9
- Uses
Primarily suitable for patients with type 2 diabetes, especially those with obesity. It has a good effect on controlling blood sugar and improving insulin sensitivity.
Thiazolidinedione Medication: アクトス錠15 (Pioglitazone)
- Mechanism of Action
アクトス錠 is a thiazolidinedione-class medication that lowers blood sugar levels by enhancing cellular sensitivity to insulin through the activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ).
https://medjp.com/products/7ee98b57699e47a4a52b2af658a66f39
- Uses
It is suitable for patients with type 2 diabetes, especially those with insulin resistance. It not only improves blood sugar but also aids in regulating blood lipids, making it a comprehensive treatment choice.
SGLT-2 Inhibitors: カナグル錠 (Canagliflozin)
- Mechanism of Action
カナグル錠 belongs to the class of SGLT-2 inhibitors, reducing blood sugar by inhibiting the reabsorption of glucose in the kidneys, leading to a substantial excretion of glucose in the urine.
https://medjp.com/products/6a48cf3f37854014a74c93d1c8bd692f
- Uses
It is applicable to patients with type 2 diabetes, especially those aiming for weight reduction and improved insulin resistance. Its unique mechanism also brings about an additional effect of weight loss.
Conclusion
By understanding these commonly prescribed diabetes medications in Japan, we can witness the distinctive approach of Japan in the field of diabetes treatment. The emphasis on personalized medication selection provides more precise treatment plans based on the specific conditions of each patient. We hope this article serves as an inspiration for readers facing diabetes issues, offering more beneficial information for their health. When using these medications, it is crucial to follow medical guidance to ensure the safe and effective management of diabetes.